Salesforce Inc CRM shares are trading lower Thursday after the company reported second-quarter results and issued guidance below analyst estimates.
Salesforce said fiscal second-quarter revenue jumped 22% year-over-year to $7.72 billion, which beat average analyst estimates of $7.7 billion, according to Benzinga Pro. The cloud company reported quarterly earnings of $1.19 per share, which beat average analyst estimates of $1.02 per share.
Salesforce expects third-quarter revenue to be between $7.82 billion and $7.83 billion versus the estimate of $8.07 billion. The company expects third-quarter adjusted earnings to be between $1.20 and $1.21 per share versus the estimate of $1.29 per share.
Salesforce said it expects full-year revenue to be between $30.9 billion and $31 billion versus the estimate of $31.73 billion. The company expects full-year adjusted earnings to be between $4.71 and $4.73 per share versus the estimate of $4.75 per share.
Salesforce also announced that its board authorized a buyback of up to $10 billion.
See Also: S&P 500, Nasdaq Futures Firm Up Ahead Of Fed Jackson Hole Event, Q2 GDP Data; Tesla In Focus Today
Analyst Assessment: Several analysts cut price targets on the stock following the company's quarterly results.
- Piper Sandler analyst Brent Bracelin maintained Salesforce with an Overweight and lowered the price target from $220 to $200.
- Credit Suisse analyst Phil Winslow maintained Salesforce with an Outperform and lowered the price target from $315 to $250.
- Citigroup analyst Tyler Radke maintained Salesforce with a Neutral and lowered the price target from $189 to $179.
- Barclays analyst Raimo Lenschow maintained Salesforce with an Overweight and lowered the price target from $218 to $202.
- JPMorgan analyst Mark Murphy maintained Salesforce with an Overweight and lowered the price target from $275 to $245.
CRM Price Action: Salesforce has a 52-week high of $256.87 and a 52-week low of $154.55.
The stock was down 7.63% at $166.27 at time of publication.
Photo: courtesy of Salesforce.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.